GRCE

Grace Therapeutics
GRCE

20 hedge funds and large institutions have $11.3M invested in Grace Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

71% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 7

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$409K
2
+$53.2K
3
+$6.74K
4
SPIA
Steward Partners Investment Advisory
New York
+$109
5
Jones Financial Companies
Jones Financial Companies
Missouri
+$77

Top Sellers

1
-$516K
2
-$444K
3
-$38.7K
4
Citadel Advisors
Citadel Advisors
Florida
-$10.7K
5
TRCT
Tower Research Capital (TRC)
New York
-$5.53K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.5M
2
$3.35M
3
$1.47M
4
$1.22M
5
$869K
6
$525K
7
$144K
8
$102K
9
$82K
10
$67K
11
$8.07K
12
$5.49K
13
$4.01K
14
$2K
15
$309
16
$300
17
$122
18
$86
19
$3
20
$3
21
–